AMARIN CORP PLC\UK Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- AMARIN CORP PLC\UK stock issued during period, value, stock options exercised for the quarter ending 2024-03-31 was $10.00K, a 99.47% decline year-over-year.
- AMARIN CORP PLC\UK stock issued during period, value, stock options exercised for the quarter ending 2023-09-30 was $2.00K, a 80.00% decline year-over-year.
- AMARIN CORP PLC\UK stock issued during period, value, stock options exercised for the quarter ending 2023-06-30 was $7.00K, a 63.16% decline year-over-year.
- AMARIN CORP PLC\UK stock issued during period, value, stock options exercised for the quarter ending 2023-03-31 was $1.87M, a 6136.67% increase year-over-year.
- AMARIN CORP PLC\UK stock issued during period, value, stock options exercised for fiscal 2024 was $10.00K, a 99.47% decline from fiscal 2023.
- AMARIN CORP PLC\UK stock issued during period, value, stock options exercised for fiscal 2023 was $1.88M, a 3036.67% increase from fiscal 2022.
- AMARIN CORP PLC\UK stock issued during period, value, stock options exercised for fiscal 2022 was $60.00K, a 97.95% decline from fiscal 2021.
- AMARIN CORP PLC\UK stock issued during period, value, stock options exercised for fiscal 2021 was $2.92M, a 43.37% decline from fiscal 2020.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2024-12-31 | $10.00K 10-K · filed 2026-03-02 | |
| 2024-03-31 | $10.00K 10-Q · filed 2025-10-29 | |
| 2023-12-31 | $1.88M 10-K · filed 2026-03-02 | |
| 2023-09-30 | $2.00K 10-Q · filed 2024-10-30 | |
| 2023-06-30 | $7.00K 10-Q · filed 2024-10-30 | |
| 2023-03-31 | $1.87M 10-Q · filed 2024-10-30 | |
| 2022-12-31 | $60.00K 10-K · filed 2024-02-29 | |
| 2022-09-30 | $10.00K 10-Q · filed 2023-11-01 | |
| 2022-06-30 | $19.00K 10-Q · filed 2023-11-01 | |
| 2022-03-31 | $30.00K 10-Q · filed 2023-11-01 | |
| 2021-12-31 | $2.92M 10-K · filed 2023-03-01 | |
| 2021-09-30 | $481.00K 10-Q · filed 2022-10-27 | |
| 2021-06-30 | $75.00K 10-Q · filed 2022-10-27 | |
| 2021-03-31 | $2.06M 10-Q · filed 2022-10-27 | |
| 2020-12-31 | $5.16M 10-K · filed 2023-03-01 | |
| 2020-09-30 | $203.00K 10-Q · filed 2021-11-03 | |
| 2020-06-30 | $352.00K 10-Q · filed 2021-11-03 | |
| 2020-03-31 | $1.31M 10-Q · filed 2021-11-03 | |
| 2019-12-31 | $24.48M 10-K · filed 2022-03-01 | |
| 2019-09-30 | $2.20M 10-Q · filed 2020-11-05 | $29.45M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $1.89M 10-Q · filed 2020-11-05 | $41.92M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $15.46M 10-Q · filed 2020-11-05 | $40.31M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $9.91M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $26.40M 10-K · filed 2021-02-25 |
| 2018-09-30 | $14.67M 10-Q · filed 2019-11-05 | $16.68M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-06-30 | $278.00K 10-Q · filed 2019-11-05 | $2.07M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-03-31 | $1.55M 10-Q · filed 2019-11-05 | $1.89M derived: sum of 4 quarters · filed 2020-02-25 |
| 2017-12-31 | $187.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $638.00K 10-K · filed 2020-02-25 |
| 2017-09-30 | $55.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | $602.00K derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-06-30 | $100.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | $559.00K derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-03-31 | $296.00K 10-Q · filed 2017-05-03 | $561.00K derived: sum of 4 quarters · filed 2019-02-27 |
| 2016-12-31 | $151.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $287.00K 10-K · filed 2019-02-27 |
| 2016-09-30 | $12.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $136.00K derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | $102.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $124.00K derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-03-31 | $22.00K 10-Q · filed 2016-05-05 | $49.00K derived: sum of 4 quarters · filed 2018-02-27 |
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $31.00K 10-K · filed 2018-02-27 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | $31.00K derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-06-30 | $27.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $54.00K derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-03-31 | $4.00K 10-Q · filed 2015-05-08 | $27.00K derived: sum of 4 quarters · filed 2017-03-01 |
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $307.00K 10-K · filed 2017-03-01 |
| 2014-09-30 | $23.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $307.00K derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $370.00K derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-03-31 | $284.00K 10-Q · filed 2014-05-09 | $472.00K derived: sum of 4 quarters · filed 2016-02-25 |
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | $627.00K 10-K · filed 2016-02-25 |
| 2013-09-30 | $86.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $998.00K derived: sum of 4 quarters · filed 2015-03-03 |
| 2013-06-30 | $102.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | $2.07M derived: sum of 4 quarters · filed 2015-03-03 |
| 2013-03-31 | $439.00K 10-Q · filed 2013-05-09 | $7.85M derived: sum of 4 quarters · filed 2015-03-03 |
| 2012-12-31 | $371.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-03 | $8.21M 10-K · filed 2015-03-03 |
| 2012-09-30 | $1.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $7.86M derived: sum of 4 quarters · filed 2014-02-27 |
| 2012-06-30 | $5.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | $6.82M derived: sum of 4 quarters · filed 2014-02-27 |
| 2012-03-31 | $791.00K 10-Q · filed 2013-05-09 | $4.16M derived: sum of 4 quarters · filed 2014-02-27 |
| 2011-12-31 | $21.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-27 | $5.09M 10-K · filed 2014-02-27 |
| 2011-09-30 | $119.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | $8.69M derived: sum of 4 quarters · filed 2013-02-28 |
| 2011-06-30 | $3.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-08 | |
| 2011-03-31 | $1.72M 10-Q · filed 2012-05-08 | |
| 2010-12-31 | $3.61M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | $3.64M 10-K · filed 2013-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B |